New chemo cocktail aims to beat back leukemia relapse
NCT ID NCT00932412
First seen Jun 26, 2026 · Last updated Jun 27, 2026 · Updated 1 time
Summary
This phase 2 trial tests whether a combination of clofarabine and intermediate-dose cytarabine (CLARA) works better than high-dose cytarabine (HDAC) alone as consolidation therapy for younger adults (18-60) with newly diagnosed acute myeloid leukemia (AML). After initial remission, 735 participants were randomized to receive three cycles of either CLARA or HDAC. The main goal is to see which regimen leads to longer disease-free survival.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
Active substance
clofarabine and cytarabine (CLARA) vs high-dose cytarabine (HDAC)
What this could lead to
If CLARA works better, it could offer a more effective consolidation option for younger AML patients, potentially reducing relapse risk.
What could go wrong
This is a phase 2 trial, so results are preliminary. The CLARA combo may not improve outcomes over standard HDAC and could have different side effects.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for ACUTE MYELOID LEUKEMIA are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
CHU - Hôtel Dieu
Nantes, 44093, France
-
CHU Dupuytren
Limoges, 87042, France
-
CHU de Brabois
Vandœuvre-lès-Nancy, 54511, France
-
Centre A. Lacassagne
Nice, 06100, France
-
Centre Henri Becquerel - CHRU ROUEN
Rouen, 76038, France
-
Centre Hospitalier Boulogne/Mer
Boulogne-sur-Mer, 62280, France
-
Centre Hospitalier Dunkerque
Dunkirk, 59395, France
-
Centre Hospitalier Huguenin
Saint-Cloud, 92210, France
-
Centre Hospitalier Meaux
Meaux, 77104, France
-
Centre Hospitalier Regional et Universitaire d'Angers
Angers, 49033, France
-
Centre Hospitalier René Dubos
Cergy-Pontoise, 95303, France
-
Centre Hospitalier Schaffner
Lens, 62307, France
-
Centre Hospitalier Valenciennes
Valenciennes, 59322, France
-
Centre Hospitalier Versailles
Le Chesnay, 78150, France
-
HIA Percy
Clamart, 92141, France
-
Hospices Civils de Lyon - Centre Hospitalier Lyon Sud
Pierre-Bénite, 69495, France
-
Hôpital Archet 1
Nice, 06202, France
-
Hôpital Avicenne - bobigny
Bobigny, 93009, France
-
Hôpital Clemenceau - chu Caen
Caen, 14033, France
-
Hôpital Dubocage
Dijon, 21000, France
-
Hôpital Haut Lévêque
Pessac, 33604, France
-
Hôpital Huriez
Lille, 59037, France
-
Hôpital Michallon
Grenoble, 38043, France
-
Hôpital Mondor
Créteil, 94010, France
-
Hôpital Purpan
Toulouse, 31059, France
-
Hôpital St Louis
Paris, 75010, France
-
Hôpital Sud - CHU Amiens
Amiens, 80054, France
-
Hôpital V. Provo
Roubaix, 59056, France
-
Hôpital Victor Dupouy
Argenteuil, 95107, France
-
Hôpital de Corbeil
Corbeil, 91100, France
-
Institut Gustave Roussy
Villejuif, 94800, France
-
Institut Paoli-Calmette
Marseille, 13273, France
-
Paris Necker
Paris, 75743, France
-
Pitié-Salpetrière
Paris, 75013, France